Catherine Prodger
29  Ergebnisse:
Personensuche X
?
2

ABCL-184 Impact of MYC and BCL2 Double Expression on Outcom..:

Poynton, Edward ; Chernucha, Emily ; Day, James...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S423-S424 , 2023
 
?
3

POSTER: ABCL-184 Impact of MYC and BCL2 Double Expression o..:

Poynton, Edward ; Chernucha, Emily ; Day, James...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S200 , 2023
 
?
11

Evaluation of the frailty characteristics and clinical outc..:

Faouzi Djebbari ; Alexandros Rampotas ; Fotios Panitsas...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752006/?tool=EBI.  , 2022
 
?
13

Inclusion/exclusion in the cohort and frailty score categor..:

Faouzi Djebbari (6004379) ; Alexandros Rampotas (11933847) ; Fotios Panitsas (11933850)...
https://figshare.com/articles/figure/Inclusion_exclusion_in_the_cohort_and_frailty_score_categories_/18175683.  , 2022
 
?
14

Reasons for discontinuation of first line VCD myeloma thera..:

Faouzi Djebbari (6004379) ; Alexandros Rampotas (11933847) ; Fotios Panitsas (11933850)...
https://figshare.com/articles/dataset/Reasons_for_discontinuation_of_first_line_VCD_myeloma_therapy_in_the_total_cohort_in_MRP_subgroups_frail_vs_intermediate_or_fit_and_in_co-morbidity_subgroups_/18175701.  , 2022
 
?
15

Overall survival (OS) by frailty (frail vs. intermediate or..:

Faouzi Djebbari (6004379) ; Alexandros Rampotas (11933847) ; Fotios Panitsas (11933850)...
https://figshare.com/articles/figure/Overall_survival_OS_by_frailty_frail_vs_intermediate_or_fit_46_months_vs_not_reached_HR_1_94_95_CI_0_89_4_2_p_0_094_/18175686.  , 2022
 
1-15